Breaking News Instant updates and real-time market news.

EQT

EQT Corporation

$19.53

1.11 (6.03%)

, LMT

Lockheed Martin

$296.04

10.62 (3.72%)

09:55
12/10/18
12/10
09:55
12/10/18
09:55

Early notable gainers among liquid option names on December 10th

Notable gainers among liquid option names this morning include EQT Corporation (EQT) $19.18 +0.79, Lockheed Martin (LMT) $292.96 +7.70, Raytheon (RTN) $169.45 +4.32, Facebook (FB) $140.75 +3.31, and Qualcomm (QCOM) $57.31 +1.31.

EQT

EQT Corporation

$19.53

1.11 (6.03%)

LMT

Lockheed Martin

$296.04

10.62 (3.72%)

RTN

Raytheon

$171.87

6.63 (4.01%)

FB

Facebook

$140.63

3.21 (2.34%)

QCOM

Qualcomm

$57.75

1.75 (3.13%)

  • 13

    Dec

EQT EQT Corporation
$19.53

1.11 (6.03%)

11/20/18
GSCO
11/20/18
UPGRADE
Target $23
GSCO
Buy
EQT Corporation upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Brian Singer upgraded EQT Corporation to Buy with a $23 price target. The analyst believes the company's production guidance calling for 5% asset sale-adjusted growth in 2019 is conservative. Further, he thinks concerns around management's five-year outlook are overdone. EQT's valuation is attractive following the recent underperformance of the shares, Singer tells investors in a research note.
11/20/18
GSCO
11/20/18
DOWNGRADE
Target $29
GSCO
Neutral
Cabot Oil & Gas downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Brian Singer downgraded Cabot Oil & Gas (COG) to Neutral with an unchanged price target of $29. The analyst sees less relative upside following the stock's recent outperformance driven by what he believes is a "temporary improvement" in natural gas prices. Singer believes other stocks in his coverage universe offer more attractive risk/rewards. The analyst this morning also upgraded EQT Corporation (EQT) to Buy from Neutral.
11/20/18
11/20/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. LyondellBasell (LYB) upgraded to Outperform from Sector Perform at RBC Capital with analyst Arun Viswanathan saying the shares look attractive when investors "look through oil and market volatility," anticipating the company to post "robust" EBITDA growth in 2019 and 2020. 2. BP (BP) upgraded to Outperform from Market Perform at Raymond James with analyst Jean-Pierre Dmirdjian saying poor year-to-date share performance has created an attractive entry point. He also said shares screen well on free cash flow, oil leverage, and production growth. 3. CME Group (CME) upgraded to Buy from Hold at Berenberg with analyst Chris Turner saying he expects "unsettled markets" in 2019 to provide a supportive backdrop for volumes in CME's core interest rate and currency products. 4. American Vanguard (AVD) upgraded to Buy from Hold at Loop Capital with analyst Chris Kapsch saying despite "much negativity" surrounding the broader agriculture end market amid the ongoing Trump/China trade war, American Vanguard is "navigating and executing admirably." 5. EQT Corporation (EQT) upgraded to Buy from Neutral at Goldman Sachs with analyst Brian Singer saying he believes the company's production guidance calling for 5% asset sale-adjusted growth in 2019 is conservative. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/05/18
MKMP
12/05/18
INITIATION
Target $28
MKMP
Buy
EQT Corporation initiated with a Buy at MKM Partners
MKM Partners analyst John Gerdes started EQT Corporation with a Buy rating and $28 price target.
LMT Lockheed Martin
$296.04

10.62 (3.72%)

10/03/18
FBCO
10/03/18
NO CHANGE
Target $368
FBCO
Neutral
Lockheed Martin price target raised to $368 from $340 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Lockheed Martin to $368 from $340 as his in-depth review of both the F-35 program and the broader business suggests that the bear case largely misses the mark. The analyst believes that Aeronautics and MFC will remain Lockheed's growth leaders over the next several years, and expects growth in Aeronautics to slow but remain positive beyond 2020 as rising F-35 sustainment revenues are only partially offset by C-130J headwinds and plateauing F-35 procurement quantities. RMS faces Black Hawk headwinds in the near-term, but growth should pick up in 2020 and beyond, he contends, adding that space should grow modestly in the near-term. The analyst reiterates a Neutral rating on the shares.
10/24/18
GSCO
10/24/18
UPGRADE
Target $394
GSCO
Conviction Buy
Lockheed Martin upgraded to Conviction Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Noah Poponak upgraded Lockheed Martin to Buy and added the shares to his firm's Conviction List. He also raised his price target for the shares to $394 from $391.
10/24/18
FBCO
10/24/18
NO CHANGE
Target $357
FBCO
Neutral
Lockheed Martin price target lowered to $357 from $368 at Credit Suisse
Credit Suisse analyst Robert Spingarn lowered his price target for Lockheed Martin to $357 from $368 following quarterly results. The analyst reiterates a Neutral rating on the shares.
10/24/18
10/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lockheed Martin (LMT) upgraded to Conviction Buy from Neutral at Goldman Sachs with analyst Noah Poponak raising his price target for the shares to $394 from $391. 2. Paccar (PCAR) upgraded to Overweight from Neutral at Piper Jaffray with analyst Alexander Potter saying Paccar's brands boasted the highest level of brand loyalty in his firm's survey of 743 U.S.-based fleets. 3. Morgan Stanley (MS) upgraded to Outperform from Market Perform at Wells Fargo with analyst Mike Mayo saying this means he now recommends 5 out of 5 of the largest U.S. wholesale banks. 4. 3D Systems (DDD) upgraded to Neutral from Underweight at Piper Jaffray with analyst Troy Jensen saying while Piper's Q3 survey "showed another poor performance" from 3D Systems' resellers, the company's "significant direct sales win" with Align Technology (ALGN) will continue to allow 3D Systems to report "impressive" year-over-year product growth for the next few quarters. 5. Lululemon (LULU) upgraded to Buy from Hold at Canaccord with analyst Camilo Lyon saying he recommends taking advantage of the recent 15% pullback as he believes the risk/reward is now skewed to the upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
RTN Raytheon
$171.87

6.63 (4.01%)

08/15/18
UBSW
08/15/18
INITIATION
Target $250
UBSW
Buy
Raytheon initiated with a Buy at UBS
UBS analyst Myles Walton initiated coverage of the Aerospace & Defense sector, starting Raytheon with a Buy rating and $250 price target.
05/24/18
STFL
05/24/18
NO CHANGE
Target $65
STFL
Buy
AeroVironment well-positioned to win new Army contract, says Stifel
Separate from AeroVironment's (AVAV) recent Switchblade contract announcement, Stifel analyst Joseph DeNardi highlighted that the Army recently posted a request for information for Switchblade production from FY19-FY26. DeNardi said it is unclear what the likelihood is that AeroVironment continues to be the sole-source Switchblade provider as it has been from FY17-FY19, as he assumes multiple contractors will reply and suspects that offerings presumably from companies like Raytheon (RTN), Textron (TXT) and possibly Lockheed (LMT) will be more mature than they were a few years ago. Still, he is encouraged by the length of the performance period for the new RFI and views AeroVironment as well-positioned to win the competition, DeNardi tells investors. He keeps a Buy rating and $65 price target on the stock.
09/21/18
MSCO
09/21/18
NO CHANGE
MSCO
Morgan Stanley says not to panic over Defense payment proposal
Morgan Stanley analyst Rajeev Lalwani attributes the underperformance in Defense stocks over the last two days compared to the broader market to heightened concerns around a month old proposal from the Department of Defense to adjust progress and performance payments down to 50% from 80% of cost, which would effectively slow the timing of cash flow receipts closer to when a project is complete. He sees a number of reasons not to panic, firstly because he believes that the Administration will not move forward with a proposal industry-players will paint as being anti-business and anti-defense spending. Even if it were to move forward, the proposal primarily impacts cash flow timing, with underlying earnings unchanged and potential offsets evident, Lalwani tells investors. Lastly, while there would be considerable uncertainty around rule implementation, the proposal would create a path to superior cash flows versus today, the analyst added. Companies in the defense contracting space include General Dynamics (GD), Huntington Ingalls (HII), L3 Technologies (LLL), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
09/21/18
09/21/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. UBS SAYS BUY AT&T: UBS analyst John Hodulik upgraded AT&T (T) to Buy and raised his price target for the shares to $38 from $33, noting that the stock is trading near all-time low valuations and at its widest valuation gap to Verizon (VZ). The Time Warner transaction and accounting changes "have compounded [other] issues, leading to a loss of visibility for investors," but his work indicates that AT&T will return to EBITDA growth in the second half of 2018, after a 6% decline in the first half, due to growth in Wireless and WarnerMedia as well as slower declines in Entertainment. JPMORGAN GOES TO BULL FROM BEAR ON NOVAVAX: JPMorgan analyst Eric Joseph double upgraded Novavax (NVAX) to Overweight from Underweight saying the risk/reward is favorable into the report of Prepare trial data in Q1 of 2019. The trial is assessing the efficacy of the company's RSV F Vaccine for infants via maternal immunization and the analyst believes the shares can hit a range of $2.00 to $2.25, he told investors. JPMORGAN SUGGESTS BEING SHORT COPART, LONG KAR: JPMorgan analyst Ryan Brinkman downgraded Copart (CPRT) to Underweight and lowered his price target for the shares to $47 from $48. The company reported softer than expected Q4 results this week but trades at "near record multiples" of earnings and EBITDA, Brinkman told investors. The analyst sees a potential pair trade in going long KAR Auction (KAR) shares, and short Copart shares, to capitalize on the "valuation disconnect." LOOP SETS $8.25 TARGET ON HARMONIC: Loop Capital analyst James Kisner initiated Harmonic (HLIT) with a Buy rating and $8.25 price target, saying he believes Harmonic can "drive robust revenue growth on its Cable Edge business as cable operators like Comcast (CMCSA, CMCSK) adopt its virtual CCAP/CMTS solution," and that the company's video business with stabilize. 'DON'T PANIC' OVER DOD PROPOSAL: Morgan Stanley analyst Rajeev Lalwani attributes the underperformance in Defense stocks over the last two days compared to the broader market to heightened concerns around a month old proposal from the Department of Defense to adjust progress and performance payments down to 50% from 80% of cost, which would effectively slow the timing of cash flow receipts closer to when a project is complete. He sees a number of reasons not to panic, mainly because he believes that the Administration will not move forward with a proposal industry-players will paint as being anti-business and anti-defense spending. Publicly-traded defense contractors include General Dynamics (GD), Huntington Ingalls (HII), L3 Technologies (LLL), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
FB Facebook
$140.63

3.21 (2.34%)

12/06/18
GUGG
12/06/18
INITIATION
Target $150
GUGG
Neutral
Facebook initiated with a Neutral due to challenges at Guggenheim
Guggenheim analyst Michael Morris initiated Facebook with a Neutral and $150 price target saying he expects challenges related to privacy, regulation, and operations monetization to continue to weight on investor sentiment and limit multiple expansion.
12/06/18
12/06/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Facebook (FB) downgraded to Hold from Buy at Stifel with analyst Scott Devitt saying Facebook has made too many enemies, including politicians, regulators, technology leaders, consumers, and employees, to not experience "long-term negative ramifications on its business." 2. Conatus (CNAT) downgraded to Hold from Buy at Stifel with analyst Stephen Willey saying the Encore-PH trial missed its pre-specified primary endpoint but post-hoc analyses demonstrated a trend towards statistically significant/emricasan-mediated improvements in patients with compensated cirrhosis and elevated baseline hepatic venous pressure gradient values. 3. BHP Billiton (BHP) downgraded to Neutral from Overweight at JPMorgan with analyst Lyndon Fagan saying the stock has outperformed Rio Tinto (RIO) by 10% year-to-date, and is now trading "within range of our valuation." 4. Toll Brothers (TOL) downgraded to Sector Perform from Outperform at RBC Capital with analyst Michael Dahl citing a "sharper than expected weakness in orders and likelihood of further near-term declines," with softer margin assumptions attributed to a weaker outlook for orders. 5. Bluebird Bio (BLUE) downgraded to Neutral from Overweight at Piper Jaffray with analyst Tyler Van Buren saying the company is "incredibly innovative" company and bb2121 and LentiGlobin are essentially curing some patients, but the benefits "are not without serious risks." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/06/18
12/06/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. LG Display (LPL) initiated with a Buy at Citi. 2. Twitter (TWTR) and Alphabet (GOOG, GOOGL) were initiated with a Buy at Guggenheim, while Snap (SNAP) and Facebook (FB) were initiated with a Neutral. 3. Apache (APA) initiated with an Overweight at Stephens. 4. CorMedix (CRMD) initiated with a Buy at Roth Capital. 5. Protagonist Therapeutics (PTGX) initiated with a Buy at Nomura Instinet. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/10/18
DBAB
12/10/18
NO CHANGE
DBAB
Buy
Facebook valuation 'extremely attractive' at current levels, says Deutsche Bank
Facebook remains the best risk/reward in large cap internet given the potential for core engagement to stabilize, for monetization in the Stories format to drive a potential re-acceleration in growth in mid-2019, for the negative news cycle to abate and given the "extremely attractive" current valuation, Deutsche Bank analyst Lloyd Walmsley tells investors in a research note. The analyst is encouraged that on top of Facebook's "relatively aggressive" share buyback to-date, the board expanded the repurchase authorization again by an additional $9B. He reiterates a Buy rating on Facebook shares.
QCOM Qualcomm
$57.75

1.75 (3.13%)

12/06/18
SUSQ
12/06/18
INITIATION
Target $90
SUSQ
Neutral
NXP Semiconductors initiated with a Neutral at Susquehanna
Susquehanna analyst Chris Roland initiated NXP Semiconductors (NXPI) with a Neutral rating and a price target of $90. The analyst expects the company to benefit from its "substantial auto exposure" but also warns that trade tensions, soft auto sales, and "contracting industry lead times" warrant a near-term pause. Roland adds that once the "Qualcomm (QCOM) hangover" subsides, NXP Semiconductors revenue will re-accelerate as the company refocuses on its core business. The analyst is further positive on the company's "diversification away from Apple (AAPL) and handsets, and focus on new growth opportunities including high-power RF's in 5G infrastructure".
12/10/18
12/10/18
DOWNGRADE

Sector Weight
Qorvo downgraded to Sector Weight at KeyBanc after demand checks
As previously reported, KeyBanc analyst Weston Twigg downgraded Qorvo (QRVO) to Sector Weight from Overweight given further weakening Apple (AAPL) iPhone demand trends, weaker than expected China smartphone demand, and indications Qualcomm (QCOM) is finally gaining market share on RF360 amid transition to 5G in 2H19. While the analyst believes Qorvo remains well positioned for 5G longer term and sees modest downside risk with the stock trading near trough valuation, Twigg struggles to see positive catalysts given the disappointing iPhone cycle and weakening demand environment for China smartphones. Overall, his quarterly Asia supply chain findings and demand checks left him incrementally more cautious on the semiconductor space.
12/10/18
KEYB
12/10/18
DOWNGRADE
KEYB
Sector Weight
Skyworks downgraded to Sector Weight at KeyBanc on weakening smartphone demand
As previously reported, KeyBanc analyst Weston Twigg downgraded Skyworks (SWKS) to Sector Weight from Overweight given further weakening Apple (AAPL) iPhone demand trends, weaker than expected China smartphone demand, indications Qualcomm (QCOM) is finally gaining market share on RF360 amid transition to 5G in 2H19, and modest share lost in China smartphones to Qorvo (QRVO) this year as a result of RF Fusion phase 6 and signs of supply constraints at Skyworks. While the analyst believes Skyworks remains well positioned for 5G longer term and sees modest downside risk with the stock trading near trough valuation, Twigg struggles to see positive catalysts given the disappointing iPhone cycle and weakening demand environment for China smartphones.
12/03/18
MSCO
12/03/18
NO CHANGE
Target $100
MSCO
Equal Weight
Morgan Stanley says 'a lot has changed' since Qualcomm first bid to buy NXP
After the White House issued a statement that noted Chinese President Xi said he is open to approving Qualcomm's (QCOM) previous bid to buy NXP Semiconductors (NXPI) if it were presented to him again, Morgan Stanley analyst Craig Hettenbach noted that "a lot has changed" since Qualcomm's initial offer. The semiconductor industry was in the midst of an upcyle at that time, but it is now in the midst of a correction that will likely mean downward estimate revision risk in 2019, Hettenbach said. If NXP were presented with another offer, he thinks the board could be open to the idea, but would likely require greater certainty of approval before committing given that the drawn out approval process was a material overhang last time. Hettenbach maintains an Equal Weight rating on NXP shares with a $100 price target.

TODAY'S FREE FLY STORIES

JD

JD.com

$33.53

-0.04 (-0.12%)

06:40
11/18/19
11/18
06:40
11/18/19
06:40
Recommendations
JD.com analyst commentary  »

JD.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

AVLR

Avalara

$72.36

0.24 (0.33%)

, GE

General Electric

$11.51

0.21 (1.86%)

06:38
11/18/19
11/18
06:38
11/18/19
06:38
Hot Stocks
Avalara names Jay Lee as Chief Marketing Officer »

Avalara (AVLR) announced…

AVLR

Avalara

$72.36

0.24 (0.33%)

GE

General Electric

$11.51

0.21 (1.86%)

AXP

American Express

$120.77

-0.18 (-0.15%)

PYPL

PayPal

$104.21

0.41 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 02

    Dec

  • 06

    Dec

  • 09

    Dec

  • 10

    Dec

  • 29

    Jan

TRMB

Trimble

$39.64

0.44 (1.12%)

, STN

Stantec

$26.43

0.41 (1.58%)

06:36
11/18/19
11/18
06:36
11/18/19
06:36
Hot Stocks
Trimble announces David Barnes as new CFO »

Trimble (TRMB) announced…

TRMB

Trimble

$39.64

0.44 (1.12%)

STN

Stantec

$26.43

0.41 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SURF

Surface Oncology

$1.80

-0.05 (-2.70%)

06:36
11/18/19
11/18
06:36
11/18/19
06:36
Hot Stocks
Surface Oncology files IND for CD39 targeted antibody candidate, SRF617 »

Surface Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

06:35
11/18/19
11/18
06:35
11/18/19
06:35
General news
FX Update: Sterling has rallied on weekend polls »

FX Update: Sterling has…

AL

Air Lease

$45.48

0.36 (0.80%)

, EADSY

Airbus

$0.00

(0.00%)

06:35
11/18/19
11/18
06:35
11/18/19
06:35
Hot Stocks
Air Lease announces lease placement of six Airbus A321-200 with Air Transat »

Air Lease (AL) announced…

AL

Air Lease

$45.48

0.36 (0.80%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNK

Teekay Tankers

$2.39

0.155 (6.94%)

06:34
11/18/19
11/18
06:34
11/18/19
06:34
Upgrade
Teekay Tankers rating change  »

Teekay Tankers upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$18.93

0.715 (3.93%)

06:33
11/18/19
11/18
06:33
11/18/19
06:33
Hot Stocks
Aerie Pharmaceuticals to acquire Avizorex Pharma, S.L. in all-cash deal »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OC

Owens Corning

$65.18

0.225 (0.35%)

06:32
11/18/19
11/18
06:32
11/18/19
06:32
Upgrade
Owens Corning rating change  »

Owens Corning upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$84.89

0.33 (0.39%)

, BAYRY

Bayer

$0.00

(0.00%)

06:32
11/18/19
11/18
06:32
11/18/19
06:32
Hot Stocks
Merck, Bayer's vericiguat meets primary endpoint in Phase 3 study »

Merck (MRK) announced…

MRK

Merck

$84.89

0.33 (0.39%)

BAYRY

Bayer

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 07

    Dec

  • 10

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

ATTO

Atento

$2.83

0.04 (1.43%)

06:32
11/18/19
11/18
06:32
11/18/19
06:32
Conference/Events
Atento to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

AERI

Aerie Pharmaceuticals

$18.93

0.715 (3.93%)

06:30
11/18/19
11/18
06:30
11/18/19
06:30
Hot Stocks
Breaking Hot Stocks news story on Aerie Pharmaceuticals »

Aerie Pharmaceuticals to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEYS

Keysight Technologies

$109.08

2.26 (2.12%)

06:30
11/18/19
11/18
06:30
11/18/19
06:30
Initiation
Keysight Technologies initiated  »

Keysight Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

BRP

BRP Group

$17.47

-0.03 (-0.17%)

06:29
11/18/19
11/18
06:29
11/18/19
06:29
Initiation
BRP Group initiated  »

BRP Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SURF

Surface Oncology

$1.80

-0.05 (-2.70%)

06:28
11/18/19
11/18
06:28
11/18/19
06:28
Conference/Events
Surface Oncology to host analyst & investor day »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

MGY

Magnolia Oil & Gas

$11.69

0.07 (0.60%)

06:28
11/18/19
11/18
06:28
11/18/19
06:28
Initiation
Magnolia Oil & Gas initiated  »

Magnolia Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$265.73

3.07 (1.17%)

, SSNLF

Samsung

$0.00

(0.00%)

06:27
11/18/19
11/18
06:27
11/18/19
06:27
Periodicals
Apple expected to capture top spot in 5G smartphone race in 2020, DigiTimes says »

Apple (AAPL) is expected…

AAPL

Apple

$265.73

3.07 (1.17%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANCN

Anchiano Therapeutics

$1.93

-0.32 (-14.22%)

06:26
11/18/19
11/18
06:26
11/18/19
06:26
Downgrade
Anchiano Therapeutics rating change  »

Anchiano Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEG

Leggett & Platt

$53.36

0.16 (0.30%)

06:26
11/18/19
11/18
06:26
11/18/19
06:26
Conference/Events
Leggett & Platt to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

SRPT

Sarepta

$97.42

-0.03 (-0.03%)

, SLDB

Solid Biosciences

$3.51

0.37 (11.78%)

06:26
11/18/19
11/18
06:26
11/18/19
06:26
Recommendations
Sarepta, Solid Biosciences analyst commentary  »

Sarepta price target…

SRPT

Sarepta

$97.42

-0.03 (-0.03%)

SLDB

Solid Biosciences

$3.51

0.37 (11.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$265.73

3.07 (1.17%)

06:25
11/18/19
11/18
06:25
11/18/19
06:25
Periodicals
Apple's iPhone 11 showing early success in China, Bloomberg reports »

Apple's iPhone 11 is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRP

BRP Group

$17.47

-0.03 (-0.17%)

06:25
11/18/19
11/18
06:25
11/18/19
06:25
Initiation
BRP Group initiated  »

BRP Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SI

Silvergate Capital

$15.11

-0.49 (-3.14%)

06:25
11/18/19
11/18
06:25
11/18/19
06:25
Initiation
Silvergate Capital initiated  »

Silvergate Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

06:23
11/18/19
11/18
06:23
11/18/19
06:23
Periodicals
WeWork plans to cut thousands from its workforce, NY Times reports »

WeWork is planning on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGB

Taseko Mines

06:22
11/18/19
11/18
06:22
11/18/19
06:22
Downgrade
Taseko Mines rating change  »

Taseko Mines downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.